Moderna Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Current Price
$48.12
+5.25%Profile
Valuation (TTM)
Market Cap$19.00B
P/E-5.95
EV$15.50B
P/B2.20
Shares Out394.94M
P/Sales8.54
Revenue$2.23B
EV/EBITDA—
Moderna Inc (MRNA) Stock News
MRNA Stock News & Headlines
Latest stock news and headlines for Moderna Inc (MRNA). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $48.12. Market cap: $19.00B. Sector: Healthcare. Industry: Biotechnology. This page aggregates the latest news articles relevant to MRNA from financial news sources, helping investors stay current on events that may impact Moderna Inc's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Moderna Inc (MRNA).